Spreading Patterns of NDM-Producing


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
03 2019
Historique:
received: 08 09 2018
accepted: 05 12 2018
pubmed: 12 12 2018
medline: 13 2 2020
entrez: 12 12 2018
Statut: epublish

Résumé

The spread of carbapenemase-producing

Identifiants

pubmed: 30530602
pii: AAC.01924-18
doi: 10.1128/AAC.01924-18
pmc: PMC6395922
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
beta lactamase NDM-5, E coli EC 3.5.2.6
beta-Lactamases EC 3.5.2.6
beta-lactamase NDM-1 EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Ann N Y Acad Sci. 2014 Sep;1323:22-42
pubmed: 25195939
Emerg Infect Dis. 2017 May;23(5):857-859
pubmed: 28418298
BMC Infect Dis. 2017 Mar 24;17(1):229
pubmed: 28340557
EBioMedicine. 2017 May;19:98-106
pubmed: 28479289
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Antimicrob Agents Chemother. 2013 Jan;57(1):674-6
pubmed: 23114767
Clin Infect Dis. 2009 Dec 1;49(11):1736-8
pubmed: 19886795
J Bacteriol. 2005 Jun;187(12):3950-9
pubmed: 15937157
Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78
pubmed: 27067320
Antimicrob Agents Chemother. 2009 Jun;53(6):2227-38
pubmed: 19307361
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Antimicrob Agents Chemother. 2015 Aug;59(8):5022-5
pubmed: 26014927
PLoS One. 2017 Sep 14;12(9):e0184720
pubmed: 28910381
J Antimicrob Chemother. 2015 Apr;70(4):1008-15
pubmed: 25558071
Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84
pubmed: 26169401
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311058
J Infect Dis. 2017 Dec 27;217(1):82-92
pubmed: 29029188
Antimicrob Agents Chemother. 2014 Dec;58(12):7347-57
pubmed: 25267672
PLoS One. 2012;7(4):e34752
pubmed: 22511964
Emerg Microbes Infect. 2012 Nov;1(11):e39
pubmed: 26038408
Lancet Infect Dis. 2011 May;11(5):355-62
pubmed: 21478057
Sci Transl Med. 2014 Sep 17;6(254):254ra126
pubmed: 25232178
mBio. 2011 Nov 01;2(6):e00204-11
pubmed: 22045989
EcoSal Plus. 2016 Oct;7(1):
pubmed: 27735785
Antimicrob Resist Infect Control. 2015 Oct 06;4:38
pubmed: 26448862
Antimicrob Agents Chemother. 1998 May;42(5):1181-6
pubmed: 9593147
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
Science. 2007 Jan 12;315(5809):251-2
pubmed: 17218529
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Antonie Van Leeuwenhoek. 2017 Oct;110(10):1281-1286
pubmed: 28204908
Microb Drug Resist. 2018 Nov;24(9):1333-1344
pubmed: 29565227
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28373197
Int J Antimicrob Agents. 2017 Aug;50(2):232-236
pubmed: 28666753
PLoS One. 2015 May 01;10(5):e0123063
pubmed: 25933288
Genome Announc. 2016 Jul 14;4(4):
pubmed: 27417839
Clin Microbiol Rev. 2017 Jan;30(1):1-22
pubmed: 27795305
Emerg Infect Dis. 2016 Sep;22(9):1675-7
pubmed: 27533255
PLoS One. 2014 Aug 11;9(8):e104984
pubmed: 25110940
Antimicrob Agents Chemother. 2014;58(2):1203-7
pubmed: 24247128
Curr Microbiol. 2013 Oct;67(4):493-8
pubmed: 23728748
Expert Rev Anti Infect Ther. 2014 Jan;12(1):91-115
pubmed: 24308710
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367

Auteurs

Yo Sugawara (Y)

Japan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan y1yo2yo3@biken.osaka-u.ac.jp.

Yukihiro Akeda (Y)

Japan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Division of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.

Hideharu Hagiya (H)

Division of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.

Noriko Sakamoto (N)

Japan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Dan Takeuchi (D)

Japan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Rathina Kumar Shanmugakani (RK)

Division of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.

Daisuke Motooka (D)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Isao Nishi (I)

Laboratory for Clinical Investigation, Osaka University Hospital, Suita, Japan.

Khwar Nyo Zin (KN)

Clinical Laboratory Department, Yangon General Hospital, Yangon, Myanmar.

Mya Mya Aye (MM)

Bacteriology Research Division, Department of Medical Research, Yangon, Myanmar.

Thuzar Myint (T)

Bacteriology Research Division, Department of Medical Research, Yangon, Myanmar.

Kazunori Tomono (K)

Division of Infection Control and Prevention, Osaka University Hospital, Suita, Japan.

Shigeyuki Hamada (S)

Japan-Thailand Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH